Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antenatal Dexamethasone for Late Preterm Deliveries
NCT05841121Phase 1Recruiting
- Sponsor
- Chulalongkorn University
- Start
- Aug 2023
- Primary completion
- Mar 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of dexamethasone in respiratory distress syndrome (RDS) and preterm birth (2 arms), sponsored by Chulalongkorn University. Primary endpoint: Rate of respiratory support at 72 hours. Started Aug 2023; status: recruiting.
02
Drugs
dexamethasone
03
Conditions
respiratory distress syndrome (RDS)preterm birth
Beyond the preview
Go deeper on NCT05841121.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05841121.